Infections and hypogammaglobulinemia in myasthenia gravis patients receiving low-dose rituximab: a real-world cohort study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Infections and Hypogammaglobulinemia Among Myasthenia Gravis Patients on Long-Term Low-Dose Rituximab: Findings from a Retrospective Cohort Analysis

  • By

  • Rongjing Guo

  • Yifan Zhang

  • Ting Gao

  • Zhe Ruan

  • Chao Sun

  • Sijia Hao

  • Yonglan Tang

  • Qingqing Wang

  • Xiaoxi Huang

  • Xiangqi Cao

  • Zhuyi Li

  • Danni Liu

  • Yu Liu

  • Ting Chang

  • August 28, 2026

Share

Original Source(s)

Infections and hypogammaglobulinemia in myasthenia gravis patients receiving low-dose rituximab: a real-world cohort study

  • by Rongjing Guo, Yifan Zhang, Ting Gao, Zhe Ruan, Chao Sun, Sijia Hao, Yonglan Tang, Qingqing Wang, Xiaoxi Huang, Xiangqi Cao, Zhuyi Li, Danni Liu, Yu Liu, Ting Chang

  • August 28, 2026

Related Content

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

Standardizing SANS in Spaceflight

NASA experts set out new diagnostic and management guidance for spaceflight-associated neuro-ocular syndrome

  • August 27, 2026

  • 4 min
Predictors of seizures after endovascular aneurysm exclusion: an updated systematic review and meta-analysis